Steven Kahn, MBChB, editor-in-chief of Diabetes Care, after American Diabetes Association (ADA) leadership blocked a ...

Especially in areas with hospital consolidation or closures, physician-owned hospitals represent a promising avenue for new ...

The American Medical Association (AMA) and the Vaccine Integrity Project announced that they will independently assess vaccine safety and effectiveness for the 2026-2027 respiratory virus season. This ...

On the first day of the PCAC meeting, a majority on the committee voted in favor of putting the free base and acetate forms ...

The FDA approved a combination tablet of 325-mg acetaminophen and 110-mg naproxen sodium (Tylenol with Naproxen) for over-the ...

Over 3 years, new users of GLP-1 drugs had a 21% lower risk of fragility fractures compared with new initiators of DPP-4 ...

The Ebola outbreak in Congo has killed over 1,000 people, reaching the grim milestone nearly three times faster than the 2014 ...

The Agency for Healthcare Research and Quality (AHRQ) cut dozens of grants last week, issuing what appeared to be batch ...

Three studies used nationally representative survey data to project how the new dyslipidemia guideline would affect ...

The World Health Organization (WHO) released updated guidelines and evidence-based recommendations to help people reduce ...

The FDA approved veligrotug (Lumvoa) for the treatment of thyroid eye disease (TED), regardless of disease activity or duration, Viridian Therapeutics announced on Friday. Veligrotug is the first ...

A target trial emulation of adults with diabetes found that GLP-1 drugs were linked to a higher risk of hair loss compared ...